Update: 14.09.2022
Last week: 35 week 2022 (29.08.2022 - 04.09.2022)
Last full month: Aug 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 121 960 | 16.7% | 3.6% | -0.1 | 24 350 104 | 17.9% | 3.6% | -0.1 | 20.9% |
| MoM | 417 416 | -10.8% | 3.8% | -2.4 | 82 975 624 | -8.9% | 3.7% | -2 | 45.5% |
| YTD | 6 996 296 | 5.6% | 5.7% | -0.1 | 1 382 616 662 | 24.3% | 5.5% | 0.2 | 8.3% |
| MAT | 13 641 352 | 29.3% | 6.3% | 1 | 2 561 131 080 | 50.5% | 5.8% | 1.2 | 8.8% |
| DEXALGIN | |||||||||
| WoW | 17 076 | -4.4% | 0.4% | 0 | 8 055 650 | -3.6% | 1.1% | 0 | -0.2% |
| MoM | 77 711 | -33.7% | 0.4% | -0.3 | 36 222 965 | -27.7% | 1.1% | -0.7 | 24.1% |
| YTD | 1 259 690 | 13.9% | 0.7% | 0.1 | 527 145 653 | 25.5% | 2.0% | 0.2 | 3.3% |
| MAT | 1 993 053 | 8.6% | 0.7% | 0 | 808 045 012 | 17.7% | 2.0% | 0.1 | 2.5% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 58 667 | 1.6% | 47.3% | 0.9 | 31 034 551 | 1.8% | 53.2% | 1 | -0.3% |
| MoM | 254 100 | -20.2% | 46.7% | -9 | 134 070 465 | -17.1% | 52.7% | -8.5 | -4.8% |
| YTD | 3 307 017 | -2.9% | 57.2% | -9.4 | 1 674 912 413 | 9.0% | 62.6% | -7.7 | 13.1% |
| MAT | 5 183 080 | 2.6% | 59.7% | -6.4 | 2 562 672 388 | 15.8% | 65.2% | -4.9 | 13.6% |
| ESPUMISAN BABY | |||||||||
| WoW | 23 721 | 0.9% | 33.9% | -0.4 | 15 428 249 | 2.0% | 47.3% | 0.2 | 2.1% |
| MoM | 102 195 | 2.1% | 34.4% | -3.4 | 65 631 384 | 3.4% | 47.2% | -3.3 | 12.1% |
| YTD | 1 018 952 | -9.3% | 38.3% | -3.6 | 631 372 804 | -3.2% | 51.7% | -5.1 | -0.8% |
| MAT | 1 558 630 | -10.4% | 38.9% | -2.5 | 951 057 533 | -2.5% | 52.7% | -2.8 | -4.6% |
| FASTUM | |||||||||
| WoW | 14 330 | -5.2% | 0.9% | 0 | 7 902 661 | -5.5% | 2.1% | -0.1 | -3.0% |
| MoM | 64 782 | -9.2% | 0.9% | -0.2 | 35 582 498 | -5.7% | 2.1% | -0.3 | 9.0% |
| YTD | 765 449 | -18.3% | 1.2% | -0.3 | 391 850 655 | -8.9% | 2.6% | -0.6 | 1.6% |
| MAT | 1 213 643 | -16.4% | 1.3% | -0.3 | 602 026 222 | -7.9% | 2.7% | -0.5 | 1.2% |
| IODOMARIN | |||||||||
| WoW | 62 668 | 2.4% | 23.0% | 0.1 | 11 739 448 | 1.1% | 10.0% | -0.1 | 1.9% |
| MoM | 253 124 | 17.3% | 22.1% | 0.9 | 48 433 431 | 12.6% | 9.8% | 0.1 | 12.8% |
| YTD | 2 035 068 | 5.5% | 19.1% | -0.1 | 407 598 840 | 12.3% | 8.7% | 0 | 5.9% |
| MAT | 3 273 119 | 23.9% | 20.5% | 2.8 | 637 059 482 | 25.4% | 9.3% | 1.1 | 7.1% |
| LIOTON | |||||||||
| WoW | 18 687 | -8.9% | 2.0% | -0.1 | 20 015 065 | -9.9% | 4.1% | -0.2 | -6.3% |
| MoM | 91 994 | -9.8% | 2.0% | -0.3 | 98 602 194 | -6.4% | 4.2% | -0.5 | 4.5% |
| YTD | 968 630 | -20.4% | 2.4% | -0.4 | 986 877 682 | 0.1% | 4.8% | -0.8 | -6.4% |
| MAT | 1 444 089 | -16.8% | 2.5% | -0.3 | 1 403 406 757 | 2.1% | 5.0% | -0.6 | -6.2% |
| MEZYM | |||||||||
| WoW | 206 851 | -2.8% | 19.8% | 0.2 | 31 844 273 | -0.8% | 14.1% | 0.3 | -3.7% |
| MoM | 932 880 | -26.4% | 19.7% | -7.7 | 141 473 772 | -27.8% | 13.9% | -5.9 | 2.3% |
| YTD | 13 520 487 | 8.2% | 28.3% | 1.2 | 2 068 838 536 | 17.7% | 20.3% | -0.1 | 3.8% |
| MAT | 21 786 894 | 15.3% | 29.8% | 2.3 | 3 219 491 690 | 21.8% | 21.6% | 0.8 | 6.3% |
| MIG 400 | |||||||||
| WoW | 141 886 | 0.3% | 2.9% | 0 | 16 841 291 | -0.0% | 2.2% | 0 | -0.2% |
| MoM | 607 220 | 2.0% | 3.0% | -0.6 | 72 302 693 | 3.7% | 2.2% | -0.3 | 24.1% |
| YTD | 5 962 987 | -7.4% | 3.5% | -0.4 | 700 237 571 | -3.6% | 2.6% | -0.5 | 3.3% |
| MAT | 9 412 606 | 1.0% | 3.5% | -0.1 | 1 090 250 605 | 4.7% | 2.7% | -0.2 | 2.5% |
| PROSTAMOL | |||||||||
| WoW | 19 210 | 0.1% | 14.6% | -0.3 | 26 759 717 | -1.6% | 15.3% | -0.6 | 2.4% |
| MoM | 84 201 | -10.2% | 15.1% | -2.8 | 118 438 306 | -8.5% | 15.9% | -2.9 | 6.5% |
| YTD | 1 137 994 | -19.0% | 19.9% | -5.1 | 1 597 555 529 | -9.1% | 21.3% | -6.1 | 1.6% |
| MAT | 1 872 640 | -11.2% | 21.3% | -3.2 | 2 540 854 631 | -2.7% | 22.7% | -4.1 | 2.3% |
| RESPERO MYRTOL | |||||||||
| WoW | 17 221 | 5.7% | 8.8% | 0 | 8 203 324 | 7.3% | 9.2% | 0.1 | 6.0% |
| MoM | 66 048 | 49.6% | 9.1% | 1.1 | 31 078 508 | 50.5% | 9.2% | 1.4 | 30.9% |
| YTD | 829 087 | 179.5% | 9.1% | 5.5 | 386 521 519 | 171.7% | 8.8% | 4.9 | 8.5% |
| MAT | 1 279 261 | 128.6% | 8.3% | 4.3 | 589 158 604 | 117.8% | 8.1% | 3.5 | 11.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 996 296 | 5.6% | 5.7% | -0.1 | 1 382 616 662 | 24.3% | 5.5% | 0.2 | 8.3% |
| DEXALGIN | 1 259 690 | 13.9% | 0.7% | 0.1 | 527 145 653 | 25.5% | 2.0% | 0.2 | 3.3% |
| ESPUMISAN (ADULTS) | 3 307 017 | -2.9% | 57.2% | -9.4 | 1 674 912 413 | 9.0% | 62.6% | -7.7 | 13.1% |
| ESPUMISAN BABY | 1 018 952 | -9.3% | 38.3% | -3.6 | 631 372 804 | -3.2% | 51.7% | -5.1 | -0.8% |
| FASTUM | 765 449 | -18.3% | 1.2% | -0.3 | 391 850 655 | -8.9% | 2.6% | -0.6 | 1.6% |
| IODOMARIN | 2 035 068 | 5.5% | 19.1% | -0.1 | 407 598 840 | 12.3% | 8.7% | 0 | 5.9% |
| LIOTON | 968 630 | -20.4% | 2.4% | -0.4 | 986 877 682 | 0.1% | 4.8% | -0.8 | -6.4% |
| MEZYM | 13 520 487 | 8.2% | 28.3% | 1.2 | 2 068 838 536 | 17.7% | 20.3% | -0.1 | 3.8% |
| MIG 400 | 5 962 987 | -7.4% | 3.5% | -0.4 | 700 237 571 | -3.6% | 2.6% | -0.5 | 3.3% |
| PROSTAMOL | 1 137 994 | -19.0% | 19.9% | -5.1 | 1 597 555 529 | -9.1% | 21.3% | -6.1 | 1.6% |
| RESPERO MYRTOL | 829 087 | 179.5% | 9.1% | 5.5 | 386 521 519 | 171.7% | 8.8% | 4.9 | 8.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 13 641 352 | 29.3% | 6.3% | 1 | 2 561 131 080 | 50.5% | 5.8% | 1.2 | 8.8% |
| DEXALGIN | 1 993 053 | 8.6% | 0.7% | 0 | 808 045 012 | 17.7% | 2.0% | 0.1 | 2.5% |
| ESPUMISAN (ADULTS) | 5 183 080 | 2.6% | 59.7% | -6.4 | 2 562 672 388 | 15.8% | 65.2% | -4.9 | 13.6% |
| ESPUMISAN BABY | 1 558 630 | -10.4% | 38.9% | -2.5 | 951 057 533 | -2.5% | 52.7% | -2.8 | -4.6% |
| FASTUM | 1 213 643 | -16.4% | 1.3% | -0.3 | 602 026 222 | -7.9% | 2.7% | -0.5 | 1.2% |
| IODOMARIN | 3 273 119 | 23.9% | 20.5% | 2.8 | 637 059 482 | 25.4% | 9.3% | 1.1 | 7.1% |
| LIOTON | 1 444 089 | -16.8% | 2.5% | -0.3 | 1 403 406 757 | 2.1% | 5.0% | -0.6 | -6.2% |
| MEZYM | 21 786 894 | 15.3% | 29.8% | 2.3 | 3 219 491 690 | 21.8% | 21.6% | 0.8 | 6.3% |
| MIG 400 | 9 412 606 | 1.0% | 3.5% | -0.1 | 1 090 250 605 | 4.7% | 2.7% | -0.2 | 2.5% |
| PROSTAMOL | 1 872 640 | -11.2% | 21.3% | -3.2 | 2 540 854 631 | -2.7% | 22.7% | -4.1 | 2.3% |
| RESPERO MYRTOL | 1 279 261 | 128.6% | 8.3% | 4.3 | 589 158 604 | 117.8% | 8.1% | 3.5 | 11.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 121 960 | 16.7% | 3.6% | -0.1 | 24 350 104 | 17.9% | 3.6% | -0.1 | 20.9% |
| DEXALGIN | 17 076 | -4.4% | 0.4% | 0 | 8 055 650 | -3.6% | 1.1% | 0 | -0.2% |
| ESPUMISAN (ADULTS) | 58 667 | 1.6% | 47.3% | 0.9 | 31 034 551 | 1.8% | 53.2% | 1 | -0.3% |
| ESPUMISAN BABY | 23 721 | 0.9% | 33.9% | -0.4 | 15 428 249 | 2.0% | 47.3% | 0.2 | 2.1% |
| FASTUM | 14 330 | -5.2% | 0.9% | 0 | 7 902 661 | -5.5% | 2.1% | -0.1 | -3.0% |
| IODOMARIN | 62 668 | 2.4% | 23.0% | 0.1 | 11 739 448 | 1.1% | 10.0% | -0.1 | 1.9% |
| LIOTON | 18 687 | -8.9% | 2.0% | -0.1 | 20 015 065 | -9.9% | 4.1% | -0.2 | -6.3% |
| MEZYM | 206 851 | -2.8% | 19.8% | 0.2 | 31 844 273 | -0.8% | 14.1% | 0.3 | -3.7% |
| MIG 400 | 141 886 | 0.3% | 2.9% | 0 | 16 841 291 | -0.0% | 2.2% | 0 | -0.2% |
| PROSTAMOL | 19 210 | 0.1% | 14.6% | -0.3 | 26 759 717 | -1.6% | 15.3% | -0.6 | 2.4% |
| RESPERO MYRTOL | 17 221 | 5.7% | 8.8% | 0 | 8 203 324 | 7.3% | 9.2% | 0.1 | 6.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 417 416 | -10.8% | 3.8% | -2.4 | 82 975 624 | -8.9% | 3.7% | -2 | 45.5% |
| DEXALGIN | 77 711 | -33.7% | 0.4% | -0.3 | 36 222 965 | -27.7% | 1.1% | -0.7 | 24.1% |
| ESPUMISAN (ADULTS) | 254 100 | -20.2% | 46.7% | -9 | 134 070 465 | -17.1% | 52.7% | -8.5 | -4.8% |
| ESPUMISAN BABY | 102 195 | 2.1% | 34.4% | -3.4 | 65 631 384 | 3.4% | 47.2% | -3.3 | 12.1% |
| FASTUM | 64 782 | -9.2% | 0.9% | -0.2 | 35 582 498 | -5.7% | 2.1% | -0.3 | 9.0% |
| IODOMARIN | 253 124 | 17.3% | 22.1% | 0.9 | 48 433 431 | 12.6% | 9.8% | 0.1 | 12.8% |
| LIOTON | 91 994 | -9.8% | 2.0% | -0.3 | 98 602 194 | -6.4% | 4.2% | -0.5 | 4.5% |
| MEZYM | 932 880 | -26.4% | 19.7% | -7.7 | 141 473 772 | -27.8% | 13.9% | -5.9 | 2.3% |
| MIG 400 | 607 220 | 2.0% | 3.0% | -0.6 | 72 302 693 | 3.7% | 2.2% | -0.3 | 24.1% |
| PROSTAMOL | 84 201 | -10.2% | 15.1% | -2.8 | 118 438 306 | -8.5% | 15.9% | -2.9 | 6.5% |
| RESPERO MYRTOL | 66 048 | 49.6% | 9.1% | 1.1 | 31 078 508 | 50.5% | 9.2% | 1.4 | 30.9% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs